These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3481760)

  • 1. Incidence of LAV/HTLV-III-positive blood donors.
    Laufs R
    Haematol Blood Transfus; 1987; 31():434-5. PubMed ID: 3481760
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for antibodies to HTLV-III/LAV in our population. A word of caution.
    Zafar MN
    J Pak Med Assoc; 1987 Apr; 37(4):84-5. PubMed ID: 3108550
    [No Abstract]   [Full Text] [Related]  

  • 3. [Donors with positive antibodies against HIV virus in Red Cross blood banks].
    Franco E; Picazo J; Mazón C; Antich JL; Lafulla C; Ribó E; Contreras E
    Sangre (Barc); 1986; 31(6):775-6. PubMed ID: 3470958
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria.
    Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G
    Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
    Abb J
    Vox Sang; 1986; 51(3):233-5. PubMed ID: 3544497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests.
    Lantin JP; Peitrequin R; Frei PC
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):487-9. PubMed ID: 3553029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counseling HIV-antibody positive blood donors.
    Van Devanter NL; Grisaffi JA; Steilen M; Scarola ME; Shipton RM; Tendler C; Pindyck J
    Am J Nurs; 1987 Aug; 87(8):1026-30. PubMed ID: 3474900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Survey of antiviral antibodies against human immunodeficiency virus in a population of 11,174 blood donors].
    Muñiz Díaz E; Madoz P; Lluch A
    Med Clin (Barc); 1987 Nov; 89(16):709-10. PubMed ID: 3480407
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus antibody screening in blood donors from India, Nigeria and Thailand.
    Kühnl P; Seidl S; Ray V; Kulkarni AG; Mba EC; Chandanayingyong D
    Vox Sang; 1987; 52(3):203-5. PubMed ID: 3300027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prevalence of human immunodeficiency virus (HIV) in blood donors in West Germany and West Berlin].
    Glück D; Koerner K; Caspari G; Elbert G; Grässmann W; Hesse R; Holzberger G; Kostuch B; Sternberger J; Vornwald A
    Beitr Infusionsther; 1988; 21():139-42. PubMed ID: 2462962
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of HTLV-III antibodies in blood donors at the German Red Cross].
    Kubanek B; Koerner K
    Dtsch Med Wochenschr; 1986 Mar; 111(13):516-7. PubMed ID: 3456890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
    Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y
    Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of anti-HIV testing of blood donors 1985-1988].
    Gathof B; Gürtler L; Bäcker U; Hesse R; Eberle J; Gathof G; Deinhardt F
    Klin Wochenschr; 1989 Jun; 67(12):646. PubMed ID: 2788771
    [No Abstract]   [Full Text] [Related]  

  • 18. Seropositivity to LAV/HTLV-III in 11 European countries.
    Ebbesen P; Melbye M; Jeffries J; Antonen J; Valle SL; Suni J; Ranki A; Krohn K; Chermann JC; Koch MA
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1453-6. PubMed ID: 3474150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].
    Pokrovskiĭ VV
    Ter Arkh; 1986; 58(10):151-4. PubMed ID: 3541273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary serological screening of the infection caused by the LAV/HTLV-III/HIV virus in Moscow].
    Pokrovskiĭ VV; Iankina ZK; Toporovskiĭ LM; Ryvkina VG; Pokrovskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):21-3. PubMed ID: 2445129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.